| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $5.9M | -23.0% |
| SG&A Expense | $6.5M | -16.2% |
| Operating Income | -$12.4M | +19.6% |
| Net Income | -$12.2M | +21.3% |
| EPS (Basic) | -$4.20 | +39.7% |
| EPS (Diluted) | -$4.20 | +39.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.9M | +18.8% |
| Short-term Investments | $9.8M | -53.9% |
| Current Assets | $16.2M | -39.8% |
| Total Assets | $16.4M | -40.0% |
| Total Liabilities | $1.0M | -38.8% |
| Stockholders' Equity | $15.3M | -40.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.4M | +27.7% |
| Capital Expenditures | $6K | +0.0% |
| Investing Cash Flow | $11.5M | +466.7% |
| Financing Cash Flow | -$140K | -100.7% |
| Free Cash Flow | -$10.5M | +27.7% |